Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2025Open Access

Emerging Technologies for Detection of Cell-Free Tumor DNA and RNA in Serum: Towards Early Cancer Detection and Monitoring

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDouglas M. Ruden

Discussion

Loading...

Member takes

Overview

Review discusses detection strategies for biomarkers in blood, highlighting gaps in longitudinal studies for early cancer detection.

Key Points

  • Detection of cell-free tumor DNA and RNA shows potential for early cancer diagnosis and monitoring, improving patient outcomes significantly.
  • Emerging technologies allow sensitive quantification of biomarkers, with DNA-PAINT enabling resolution of mutations and methylation patterns.
  • Assessment focuses on liquid biopsy approaches to identify cancer-specific alterations, aiding in prognosis and treatment decisions.
  • Further research is needed to integrate multi-omic strategies for better diagnosis and monitoring of cancer progression and relapse.

Cite This Study

Douglas M. Ruden (2025) studied this question.

synapsesocial.com/papers/68af409acf1dd9ea359ec71fhttps://doi.org/10.20944/preprints202508.1357.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Genome-wide cell-free DNA fragmentation in patients with cancer2019 · 1,563 citations